stockrowCareDx, Inc. (CDNA) vs NeoGenomics, Inc. (NEO)
- CareDx, Inc. CDNA 78.10 +2.32%
- NeoGenomics, Inc. NEO 16.89 +2.43%
CareDx, Inc. and NeoGenomics, Inc. are both Diagnostics & Research companies. CareDx, Inc. is the larger, with a market value of $4.0B against $2.1B — 1.9× the size. NeoGenomics, Inc. has negative trailing earnings, so its P/E is not meaningful; CareDx, Inc. trades at 30.9×. CareDx, Inc. grew revenue faster over the last twelve months: 38.9% against 11.1%. CareDx, Inc. has the higher net margin (25.9% vs −4.10%) and the higher return on invested capital (33.6% vs −2.97%). Across the 19 metrics below, CareDx, Inc. leads on 13 and NeoGenomics, Inc. on 6.
Valuation
Profitability
| Metric | CDNA | NEO | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 70.97% | 44.77% | 48.32% |
| Operating margin | 23.42% | (6.27%) | (5.68%) |
| Net margin | 25.86% | (4.10%) | (4.10%) |
| Free cash flow margin | 12.01% | (3.37%) | 0.00% |
| Return on equity | 33.04% | (3.94%) | 0.00% |
| Return on assets | 23.96% | (2.35%) | (6.05%) |
| Return on invested capital | 33.56% | (2.97%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack